A Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus

dc.date.accessioned2022-02-17T19:23:13Z
dc.date.available2022-02-17T19:23:13Z
dc.date.created2022-02-17T19:23:13Z
dc.date.issued2022
dc.identifierhttps://hdl.handle.net/20.500.12866/11385
dc.identifierhttps://doi.org/10.1097/RHU.0000000000001265
dc.description.abstractPatients with systemic lupus erythematosus (SLE) in Latin America differ to a certain extent from lupus patients in other parts of the world, particularly those from developed countries as reported over the last several years by the GLADEL group (Grupo Latino Americano de Estudio de Lupus or Latin American Group for the Study of Lupus). In the early 2000s, GLADEL constituted a Latin American cohort of SLE patients; in the initial publication in 2004, 1214 patients were included; since then, the group has reported on the presentation and course of the disease, paying particular attention to the impact of ethnic...
dc.languageeng
dc.publisherWolters Kluwer Health
dc.relationJournal of Clinical Rheumatology
dc.relation1536-7355
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPractice Guidelines as Topic
dc.subjectLupus Erythematosus, Systemic
dc.subjectRevisión
dc.subjectLatin America/etnología
dc.titleA Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución